Cargando…

Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy

It is well known that Arginine-Glycine-Aspartic acid (RGD) and Asparagine-Glycine-Arginine (NGR) peptides preferentially bind to integrin receptors and aminopeptidase N respectively and these two receptors play important roles in angiogenesis. Therefore ketoprofen as a non-selective cox Inhibitor wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokri, Bahareh, Zarghi, Afshin, Shahhoseini, Soraya, Mohammadi, Reza, Kobarfard, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269559/
https://www.ncbi.nlm.nih.gov/pubmed/30568688
_version_ 1783376497511235584
author Shokri, Bahareh
Zarghi, Afshin
Shahhoseini, Soraya
Mohammadi, Reza
Kobarfard, Farzad
author_facet Shokri, Bahareh
Zarghi, Afshin
Shahhoseini, Soraya
Mohammadi, Reza
Kobarfard, Farzad
author_sort Shokri, Bahareh
collection PubMed
description It is well known that Arginine-Glycine-Aspartic acid (RGD) and Asparagine-Glycine-Arginine (NGR) peptides preferentially bind to integrin receptors and aminopeptidase N respectively and these two receptors play important roles in angiogenesis. Therefore ketoprofen as a non-selective cox Inhibitor was conjugated with linear RGD and NGR to take advantage of targeting capability of these two motifs and delivering ketoprofen to these cancer cells with overexpression of integrin and aminopeptidase N. In order to investigate the impact of possible steric hindrance due to the attachment of the drug to the peptide, a linear six carbon (hexanoic acid) linker was also used as a spacer. Cytotoxic effect of the synthesized compounds was evaluated against a group of cancer cell lines, including MCF-7, A2780 (α(v)β(3) positive), OVCAR3 (high α(v)β(3)), HT-1-80 (high CD13) and SKOV-3 (CD13 positive). Both NGR and RGD conjugated forms of ketoprofen showed higher cytotoxic activity against OVCAR3 and HT-1-80 respectively.
format Online
Article
Text
id pubmed-6269559
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-62695592018-12-19 Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy Shokri, Bahareh Zarghi, Afshin Shahhoseini, Soraya Mohammadi, Reza Kobarfard, Farzad Iran J Pharm Res Original Article It is well known that Arginine-Glycine-Aspartic acid (RGD) and Asparagine-Glycine-Arginine (NGR) peptides preferentially bind to integrin receptors and aminopeptidase N respectively and these two receptors play important roles in angiogenesis. Therefore ketoprofen as a non-selective cox Inhibitor was conjugated with linear RGD and NGR to take advantage of targeting capability of these two motifs and delivering ketoprofen to these cancer cells with overexpression of integrin and aminopeptidase N. In order to investigate the impact of possible steric hindrance due to the attachment of the drug to the peptide, a linear six carbon (hexanoic acid) linker was also used as a spacer. Cytotoxic effect of the synthesized compounds was evaluated against a group of cancer cell lines, including MCF-7, A2780 (α(v)β(3) positive), OVCAR3 (high α(v)β(3)), HT-1-80 (high CD13) and SKOV-3 (CD13 positive). Both NGR and RGD conjugated forms of ketoprofen showed higher cytotoxic activity against OVCAR3 and HT-1-80 respectively. Shaheed Beheshti University of Medical Sciences 2018 /pmc/articles/PMC6269559/ /pubmed/30568688 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Shokri, Bahareh
Zarghi, Afshin
Shahhoseini, Soraya
Mohammadi, Reza
Kobarfard, Farzad
Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
title Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
title_full Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
title_fullStr Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
title_full_unstemmed Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
title_short Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
title_sort design, synthesis and biological evaluation of ketoprofen conjugated to rgd/ngr for targeted cancer therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269559/
https://www.ncbi.nlm.nih.gov/pubmed/30568688
work_keys_str_mv AT shokribahareh designsynthesisandbiologicalevaluationofketoprofenconjugatedtorgdngrfortargetedcancertherapy
AT zarghiafshin designsynthesisandbiologicalevaluationofketoprofenconjugatedtorgdngrfortargetedcancertherapy
AT shahhoseinisoraya designsynthesisandbiologicalevaluationofketoprofenconjugatedtorgdngrfortargetedcancertherapy
AT mohammadireza designsynthesisandbiologicalevaluationofketoprofenconjugatedtorgdngrfortargetedcancertherapy
AT kobarfardfarzad designsynthesisandbiologicalevaluationofketoprofenconjugatedtorgdngrfortargetedcancertherapy